ABVC BioPharma ABVC
The Company entered into a binding term sheet with Xinnovation Therapeutics Co., Ltd.
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-23-062628
- Document
- 8-K
- Exhibit 10.1
- Term sheet dated July 31, 2023
- Exhibit 99.1
- Press release dated August 1, 2023
- Signs a material agreement (1.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Karyopharm Therapeutics KPTI public float $37M, Jun 30, 2025
- BriaCell Therapeutics BCTX public float $37M, Jan 30, 2026
- Annovis Bio ANVS public float $36M, Jun 30, 2025
- Atara Biotherapeutics ATRA public float $39M, Jun 30, 2025
- Grace Therapeutics GRCE public float $35M, Sep 30, 2025
